Taiwan · Delayed Price · Currency is TWD GeneReach Biotechnology Statistics
Total Valuation
TPEX:4171 has a market cap or net worth of TWD 991.34 million. The enterprise value is 925.37 million.
| Market Cap | 991.34M |
| Enterprise Value | 925.37M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4171 has 57.30 million shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | 57.30M |
| Shares Outstanding | 57.30M |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 5.25% |
| Owned by Institutions (%) | n/a |
| Float | 43.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.26 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.51 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -10.22 |
| Interest Coverage | -11.78 |
Financial Efficiency
Return on equity (ROE) is -16.50% and return on invested capital (ROIC) is -13.57%.
| Return on Equity (ROE) | -16.50% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -13.57% |
| Return on Capital Employed (ROCE) | -10.53% |
| Weighted Average Cost of Capital (WACC) | 5.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | 1.92 |
Taxes
| Income Tax | -3.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.96% in the last 52 weeks. The beta is 0.40, so TPEX:4171's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -23.96% |
| 50-Day Moving Average | 18.44 |
| 200-Day Moving Average | 19.42 |
| Relative Strength Index (RSI) | 34.84 |
| Average Volume (20 Days) | 113,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4171 had revenue of TWD 232.55 million and -105.32 million in losses. Loss per share was -1.85.
| Revenue | 232.55M |
| Gross Profit | 165.11M |
| Operating Income | -70.83M |
| Pretax Income | -111.49M |
| Net Income | -105.32M |
| EBITDA | -16.13M |
| EBIT | -70.83M |
| Loss Per Share | -1.85 |
Balance Sheet
The company has 290.94 million in cash and 215.54 million in debt, with a net cash position of 75.40 million or 1.32 per share.
| Cash & Cash Equivalents | 290.94M |
| Total Debt | 215.54M |
| Net Cash | 75.40M |
| Net Cash Per Share | 1.32 |
| Equity (Book Value) | 592.98M |
| Book Value Per Share | 10.29 |
| Working Capital | 289.70M |
Cash Flow
In the last 12 months, operating cash flow was -15.11 million and capital expenditures -5.99 million, giving a free cash flow of -21.10 million.
| Operating Cash Flow | -15.11M |
| Capital Expenditures | -5.99M |
| Depreciation & Amortization | 54.70M |
| Net Borrowing | -46.10M |
| Free Cash Flow | -21.10M |
| FCF Per Share | -0.37 |
Margins
Gross margin is 71.00%, with operating and profit margins of -30.46% and -45.29%.
| Gross Margin | 71.00% |
| Operating Margin | -30.46% |
| Pretax Margin | -47.94% |
| Profit Margin | -45.29% |
| EBITDA Margin | -6.94% |
| EBIT Margin | -30.46% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:4171 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.12% |
| Shareholder Yield | 1.12% |
| Earnings Yield | -10.62% |
| FCF Yield | -2.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.
| Last Split Date | Jul 28, 2023 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
TPEX:4171 has an Altman Z-Score of 2.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 4 |